{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:57:41Z","timestamp":1781765861527,"version":"3.54.5"},"reference-count":35,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"unspecified","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004417","name":"Global Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,2,7]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine patients\u2019 acceptability, satisfaction and adherence to shorter all-oral multidrug-resistant tuberculosis (MDR-TB) regimen in Tanzania.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A two-phase cross-sectional study with data collected within 6 months of Removed Injectable modified Short-course regimens for EXpert MDR-TB (RISE) study implementation and the second phase within 15 months of implementation using the same reference populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings<\/jats:title>\n                    <jats:p>18 health facilities across eight regions of Tanzania.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Rifampicin-resistant TB\/MDR-TB patients enrolled in the RISE study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>We assessed patients\u2019 acceptability, adherence and satisfaction with the regimen using an interval scale structured questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The majority of the patients found the shorter oral MDR-TB treatment acceptable, adhered to it well and were generally satisfied. The median score (IQR) for acceptability was 1.7 (1.03\u20132.00) but it ranged between 1.3 (1.3\u20132) and 1.7 (1\u20131.79) for the first and second phases, respectively. Regarding adherence, the median score (IQR) stood at 4 (3.67\u20134.67) with scores significantly higher in the second phase at 4.33 (4.00\u20135.007) compared with the first at 4.67 (4.00\u20135.0), p value=0.01. The overall satisfaction was high at 1.5 (1.33\u22121.78) but it ranged between 1.22 (1.00\u20131.78) and 1.42 (1.11\u20131.78) for the first and second phases, respectively. Worrying about side effects was statistically associated with adherence (p value&lt;0.05). No statistically significant associations were found for acceptability and satisfaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Generally, the modified shorter oral MDR-TB regimen was accepted, and patients reported good adherence and were satisfied. More engagement with patients could provide more insights into factors that can maximise acceptability, adherence and satisfaction with the regimen.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-088556","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:05:54Z","timestamp":1741115154000},"page":"e088556","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Patients\u2019 acceptability, adherence and satisfaction on the modified shorter all-oral multidrug-resistant tuberculosis regimen: a two-phase cross-sectional study in Tanzania"],"prefix":"10.1136","volume":"15","author":[{"given":"Julieth","family":"Lalashowi","sequence":"first","affiliation":[{"name":"Tuberculosis and Emerging Diseases, National Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Happiness","family":"Mvungi","sequence":"additional","affiliation":[{"name":"Medical, Kibong\u2019oto Infectious Diseases Hospital, Sanya Juu, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zawadi","family":"Mwaisango","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-5682","authenticated-orcid":false,"given":"Doreen","family":"Pamba","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athuman","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Kibong\u2019oto Infectious Disease Hospital, Moshi, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gitige","sequence":"additional","affiliation":[{"name":"Medical, Kibong\u2019oto Infectious Diseases Hospital, Kilimanjaro, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pendomartha Joseph","family":"Shayo","sequence":"additional","affiliation":[{"name":"Medical, Kibong\u2019oto Infectious Diseases Hospital, Kilimanjaro, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Lekule","sequence":"additional","affiliation":[{"name":"National Tuberculosis and Leprosy Programme, Dodoma, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamim","family":"Omary","sequence":"additional","affiliation":[{"name":"National Tuberculosis and Leprosy Programme, Dodoma, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riziki","family":"Kisonga","sequence":"additional","affiliation":[{"name":"Medical, Kibong\u2019oto Infectious Diseases Hospital, Kilimanjaro, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Matechi","sequence":"additional","affiliation":[{"name":"National Tuberculosis and Leprosy Programme, Dodoma, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0660-6930","authenticated-orcid":false,"given":"Stellah G","family":"Mpagama","sequence":"additional","affiliation":[{"name":"Medical, Kibong\u2019oto Infectious Diseases Hospital, Kilimanjaro, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willyhelmina","family":"Olomi","sequence":"additional","affiliation":[{"name":"Data Management, Mbeya Medical Research Center, Mbeya, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyanda Elias","family":"Ntinginya","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2318-2949","authenticated-orcid":false,"given":"Albino","family":"Kalolo","sequence":"additional","affiliation":[{"name":"Public Health, Saint Francis University College of Health and Allied Sciences, Ifakara, Tanzania, United Republic of"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"2025121403542838000_15.3.e088556.1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00803-2016","article-title":"An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis","volume":"49","author":"Bastos","year":"2017","journal-title":"Eur Respir J"},{"key":"2025121403542838000_15.3.e088556.2","unstructured":"World Health Organization . WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, Online Annexes WHO Rep Geneva. 2020."},{"key":"2025121403542838000_15.3.e088556.3","unstructured":"World Health Organization . Global Tuberculosis Report. 2021."},{"key":"2025121403542838000_15.3.e088556.4","unstructured":"Ministry of Health CDGE and C . Manual for management of Tuberculosis and Leprosy in Tanzania, 7th edition. 2020."},{"key":"2025121403542838000_15.3.e088556.5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40001-021-00502-0","article-title":"Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China","volume":"26","author":"Zhang","year":"2021","journal-title":"Eur J Med Res"},{"key":"2025121403542838000_15.3.e088556.6","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaa108","article-title":"Clinical characteristics and treatment outcomes of patients with MDR tuberculosis in Dar Es Salaam region, Tanzania","volume":"2","author":"Myemba","year":"2020","journal-title":"JAC Antimicrob Resist"},{"key":"2025121403542838000_15.3.e088556.7","unstructured":"Mpagama S , Nyanda E , Kalolo A , et al . (R)emoved (I)njectable modified (S)hort \u2013 course regimens for (E)Xpert Multidrug Resistant Tuberculosis: Programmatic Feasibility and Clinical Effectiveness in Tanzania [Unpublished protocol]. 2020."},{"key":"2025121403542838000_15.3.e088556.8","doi-asserted-by":"crossref","unstructured":"Sekhon M , Cartwright M , Francis JJ . Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res 2017;17. doi:10.1186\/s12913-017-2031-8","DOI":"10.1186\/s12913-017-2031-8"},{"key":"2025121403542838000_15.3.e088556.9","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17155626","article-title":"Factors Influencing Patient Adherence to Tuberculosis Treatment in Ethiopia: A Literature Review","volume":"17","author":"Nezenega","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2025121403542838000_15.3.e088556.10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023669","article-title":"A multifaceted study of hospital variables and interventions to improve inpatient satisfaction in a multi-hospital system","volume":"99","author":"Puppala","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2025121403542838000_15.3.e088556.11","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-13-110","article-title":"Patient satisfaction on tuberculosis treatment service and adherence to treatment in public health facilities of Sidama zone, South Ethiopia","volume":"13","author":"Nezenega","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"2025121403542838000_15.3.e088556.12","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2025121403542838000_15.3.e088556.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-018-3222-7","article-title":"The acceptability, effectiveness, and impact of different models of care for pediatric weight management services: protocol for a concurrent mixed-methods study","volume":"18","author":"Cohen","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"2025121403542838000_15.3.e088556.14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ckj\/sfx141","article-title":"Acceptability of a multilevel intervention to improve blood pressure control among patients with chronic kidney disease in a public health care delivery system","volume":"11","author":"Strait","year":"2018","journal-title":"Clin Kidney J"},{"key":"2025121403542838000_15.3.e088556.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009002","article-title":"A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis","volume":"15","author":"Krentel","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121403542838000_15.3.e088556.16","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-007-9266-z"},{"key":"2025121403542838000_15.3.e088556.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054434","article-title":"Implementation of the \u201cRemoved Injectable modified Short-course regimens for EXpert Multidrug Resistant Tuberculosis\u201d (RISE study) in Tanzania: a protocol for a mixed-methods process evaluation","volume":"12","author":"Kalolo","year":"2022","journal-title":"BMJ Open"},{"key":"2025121403542838000_15.3.e088556.18","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-13-1190","article-title":"What is actually measured in process evaluations for worksite health promotion programs: a systematic review","volume":"13","author":"Wierenga","year":"2013","journal-title":"BMC Public Health"},{"key":"2025121403542838000_15.3.e088556.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2005.00356.x"},{"key":"2025121403542838000_15.3.e088556.20","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2011.38"},{"key":"2025121403542838000_15.3.e088556.21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jiph.2016.11.018","article-title":"Factors contributing to non-adherence with treatment among TB patients in Sodo Woreda, Gurage Zone, Southern Ethiopia: A qualitative study","volume":"10","author":"Gugssa Boru","year":"2017","journal-title":"J Infect Public Health"},{"key":"2025121403542838000_15.3.e088556.22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1715163513500208","article-title":"Reducing pill burden and helping with medication awareness to improve adherence","volume":"146","author":"Farrell","year":"2013","journal-title":"Can Pharm J"},{"key":"2025121403542838000_15.3.e088556.23","doi-asserted-by":"publisher","DOI":"10.1007\/s10865-007-9147-y"},{"key":"2025121403542838000_15.3.e088556.24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.625078","article-title":"Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients","volume":"12","author":"Bea","year":"2021","journal-title":"Front Pharmacol"},{"key":"2025121403542838000_15.3.e088556.25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2147\/PPA.S219920","article-title":"Drug Non-Adherence And Reasons Among Multidrug-Resistant Tuberculosis Patients In Guizhou, China: A Cross-Sectional Study","volume":"13","author":"Wang","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"2025121403542838000_15.3.e088556.26","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-015-1452-x","article-title":"Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, Northeast Ethiopia","volume":"8","author":"Tesfahuneygn","year":"2015","journal-title":"BMC Res Notes"},{"key":"2025121403542838000_15.3.e088556.27","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2147\/IDR.S293583","article-title":"Adherence to Multidrug Resistant Tuberculosis Treatment and Case Management in Chongqing, China - A Mixed Method Research Study","volume":"14","author":"Xing","year":"2021","journal-title":"Infect Drug Resist"},{"key":"2025121403542838000_15.3.e088556.28","doi-asserted-by":"crossref","DOI":"10.1186\/s41043-017-0132-y","article-title":"Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study","volume":"37","author":"Gebreweld","year":"2018","journal-title":"J Health Popul Nutr"},{"key":"2025121403542838000_15.3.e088556.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-017-4188-9","article-title":"The prevalence and factors associated for anti-tuberculosis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in South Ethiopia: a cross-sectional study","volume":"17","author":"Woimo","year":"2017","journal-title":"BMC Public Health"},{"key":"2025121403542838000_15.3.e088556.30","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-13-424","article-title":"Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia: a qualitative study","volume":"13","author":"Tadesse","year":"2013","journal-title":"BMC Public Health"},{"key":"2025121403542838000_15.3.e088556.31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5588\/pha.21.0031","article-title":"Hear us! Accounts of people treated with injectables for drug-resistant TB","volume":"11","author":"Almeida","year":"2021","journal-title":"Public Health Action"},{"key":"2025121403542838000_15.3.e088556.32","article-title":"A Comprehensive Review on Long vs. Short Regimens in Multidrug-Resistant Tuberculosis (MDR-TB) Under Programmatic Management of Drug-Resistant Tuberculosis (PMDT)","volume":"16","author":"Karnan","year":"2024","journal-title":"Cureus"},{"key":"2025121403542838000_15.3.e088556.33","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03300-2020","article-title":"World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update","volume":"57","author":"Mirzayev","year":"2021","journal-title":"Eur Respir J"},{"key":"2025121403542838000_15.3.e088556.34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01030-2018","article-title":"Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review","volume":"53","author":"Law","year":"2019","journal-title":"Eur Respir J"},{"key":"2025121403542838000_15.3.e088556.35","unstructured":"Maynard C , Tariq S , Sotgiu G , et al . Psychosocial support interventions to improve treatment outcomes for people living with tuberculosis: a mixed methods systematic review and meta-analysis, Available: https:\/\/www.thelancet.com\/journals\/eclinm\/article\/PIIS2589-5370(23)00234-1\/fulltext"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-088556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:54:40Z","timestamp":1765713280000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-088556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,4]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjopen-2024-088556"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-088556","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}